Abiopharma

Agenus Inc. - Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial

Satellos to Present Clinical Program Updates at ICNMD 2026

Constellation Announces Extension of Expiration for Exchange Offers

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

e‑STORAGE to Deliver 426 MWh of Energy Storage in Florida

Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend

Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power